"According to the chairman on 19th October 2017
As previously reported FDA approval is expected to be in the early part of 2018 ....."
That was back when Alan Hoffman and Co were directors.
I have a suspicion that one reason for all the disputes related in part to faulty communication or understanding of when FDA approval would commence or be granted.
There were obviously other factors too, but finding out that FDA approval hadn't even commenced when you were announcing it would be received could lead to real antagonism I would have thought.
"According to the chairman on 19th October 2017 As previously...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $8.406K | 53.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 36100 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2467 | 1 |
View Market Depth
| Last trade - 10.28am 26/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
